The Mode-Of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients With Bone Metastasis

International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms20163899
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Radium-223 for the Treatment of Patients With Castration-Resistant Prostate Cancer With Bone Metastases

Medical Council
2018English

Radionuclide Therapy With Radium-223 Chloride. A Few Strokes to the Patient’s Portrait

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

Radium-223 for the Management of Bone Metastases in Castration-Resistant Prostate Cancer

Journal of the Advanced Practitioner in Oncology
2015English

An in Vivo shRNA-Drug Screen to Identify Novel Targeted Therapy Combinations for KRAS Mutant Cancers

2014English

Treatment of Castration-Resistant Prostate Cancer and Bone Metastases With Radium-223 Dichloride

International Journal of Urological Nursing
UrologyNursingNephrology
2014English

Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

Alpha-Emitter Radium-223 in the Management of Solid Tumors: Current Status and Future Directions

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2014English

An Appendix of Radionuclides Used in Targeted Alpha Therapy

Journal of Medical Imaging and Radiation Sciences
RadiologicalRadiologyNuclear MedicineUltrasound TechnologyImaging
2019English

Radium-223 Auch in Kombination Möglich

Info Onkologie
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy